Early pancreatic cancer check for Swiss adults at higher risk
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at a new way to find pancreatic cancer early in people who are at higher risk because of age, new diabetes with weight loss, or family history/gene changes. If you qualify, you'd have an MRI scan to check for cancer, and the study helps see if this approach works in Swiss doctor's offices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 or older.
- You must be a patient at a participating doctor's office in the Zurich area (or nearby within 1 hour drive), or sign up through the study website.
- You need to meet at least one of the following: (1) you were diagnosed with type 2 diabetes in the last 2 years and have lost more than 5% of your body weight in the last 3 months without trying, OR (2) you have a family history of pancreatic cancer (2 or more close relatives, or 1 close relative), OR (3) you carry a known BRCA1/2 or CDKN2A gene change.
- You must be able to read and speak either German or English well enough for study visits.
- You must not have had pancreatic cancer or a pre-cancerous pancreas condition before.
- You must be able to have an MRI (no metal implants, no severe claustrophobia without an alternative).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
Hear when a new Early Detection of Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.